BioSpace News Archive

Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for DEXTENZA (dexamethasone ophthalmic insert

Shepherd Search Group is excited to announce the expansion of their Life Sciences Division. Ed Canning, an industry leader, has been appointed Managing Director of Shepherd’s Regulatory Affairs Team

Growing emphasis on early detection and prevention is driving the melanoma cancer diagnostics market, with global revenue surpassing US$ 800 million in 2018, according to a new study conducted by Fact.MR.

Howard University Hospital and its team of healthcare experts have signed on to participate at the 2019 NBC4 Health and Fitness EXPO this Saturday, January 12, at the Walter E. Washington Convention Center in Downtown, Washington, D.C.

Integration of xDM With LG’s Guide Robot Represents Blueprint for Wider Cooperation Between NAVER and LG

Topix Pharmaceuticals, the leading independent provider of premium, custom and branded skincare, today announced the appointment of Brenda Wu as President and CEO.

The Vitamin Shoppe® (NYSE: VSI), an omni-channel specialty retailer of nutritional products, has welcomed Kris Gethin to its Wellness Council

On a recent Dr. Ruscio Radio podcast featuring Board-certified Urologist, Dr. Judson Brandeis, and best-selling author of Healthy Gut, Healthy You, Dr. Michael Ruscio, the two physicians lift the veil on a male health topic that is largely ignored.

Danette Wilson, President and Chief Executive Officer (CEO), Blue Cross and Blue Shield of Kansas City (Blue KC), announced today that she will retire after more than three decades with the company, including nearly five years as its top executive

Recent reports published by PharmaForce International (PFI) provide 2018 competitive benchmarking data of leading pharmaceutical companies’ strategies for leveraging the field medical function in Europe.